Bjornsson T D, Nash P V
Am J Clin Pathol. 1986 Aug;86(2):199-204. doi: 10.1093/ajcp/86.2.199.
Activated partial thromboplastin time (APTT) is the most widely used coagulation test for monitoring heparin therapy. This study quantitates the differences in heparin sensitivity of seven commercially available APTT reagents, using plasma samples obtained from 20 subjects. The reagents studied were Actin, Actin FS, Automated APTT, Cephotest, Coagachek KAPTT, Platelin plus activator, and Activated Thrombofax. The relationship between plasma heparin and APTT was established for all reagents in each subject. For each reagent studied there was a marked intersubject variability in heparin sensitivity. There was also a marked difference in heparin sensitivity among the different reagents. The average plasma heparin activities required to double baseline APTT values ranged from 0.19 +/- 0.04 (mean +/- SD) unit/mL for the most sensitive reagents (Platelin and Actin FS) to 0.43 +/- 0.12 unit/mL for the least sensitive reagent (Actin). It is concluded that reagent variability may significantly contribute to overdosage and under dosage of heparin in the individual patient. These results stress that a standard APTT reagent be developed.
活化部分凝血活酶时间(APTT)是监测肝素治疗最常用的凝血试验。本研究使用从20名受试者获得的血浆样本,对7种市售APTT试剂的肝素敏感性差异进行了定量分析。所研究的试剂有Actin、Actin FS、Automated APTT、Cephotest、Coagachek KAPTT、Platelin plus activator和Activated Thrombofax。在每个受试者中为所有试剂建立了血浆肝素与APTT之间的关系。对于所研究的每种试剂,肝素敏感性在受试者之间存在显著差异。不同试剂之间的肝素敏感性也存在显著差异。使基线APTT值翻倍所需的平均血浆肝素活性范围为,最敏感的试剂(Platelin和Actin FS)为0.19±0.04(平均值±标准差)单位/毫升,最不敏感的试剂(Actin)为0.43±0.12单位/毫升。得出的结论是,试剂的变异性可能显著导致个体患者肝素的过量和不足使用。这些结果强调应开发一种标准的APTT试剂。